BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19437506)

  • 1. Increased prevalence of risk factors for morbidity and mortality in the US Hispanic CF population.
    Watts KD; Seshadri R; Sullivan C; McColley SA
    Pediatr Pulmonol; 2009 Jun; 44(6):594-601. PubMed ID: 19437506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.
    Emerson J; Rosenfeld M; McNamara S; Ramsey B; Gibson RL
    Pediatr Pulmonol; 2002 Aug; 34(2):91-100. PubMed ID: 12112774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive mechanical ventilation for acute respiratory failure in children with cystic fibrosis: outcome analysis and case-control study.
    Berlinski A; Fan LL; Kozinetz CA; Oermann CM
    Pediatr Pulmonol; 2002 Oct; 34(4):297-303. PubMed ID: 12205571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatobiliary abnormalities and disease in cystic fibrosis: epidemiology and outcomes through adulthood.
    Bhardwaj S; Canlas K; Kahi C; Temkit M; Molleston J; Ober M; Howenstine M; Kwo PY
    J Clin Gastroenterol; 2009 Oct; 43(9):858-64. PubMed ID: 19525864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is significant cystic fibrosis-related liver disease a risk factor in the development of bone mineralization abnormalities?
    Alex G; Catto-Smith AG; Ditchfield M; Roseby R; Robinson PJ; Cameron FJ; Oliver MR
    Pediatr Pulmonol; 2006 Apr; 41(4):338-44. PubMed ID: 16477657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data.
    Lai HJ; Cheng Y; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S57-63. PubMed ID: 16202784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk of urolithiasis in patients with cystic fibrosis].
    Campuzano S; Díaz JJ; Bousoño C; Rodríguez M; Campos C; Málaga S
    Nefrologia; 2009; 29(1):61-6. PubMed ID: 19240773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved pulmonary and growth outcomes in cystic fibrosis by newborn screening.
    Collins MS; Abbott MA; Wakefield DB; Lapin CD; Drapeau G; Hopfer SM; Greenstein RM; Cloutier MM
    Pediatr Pulmonol; 2008 Jul; 43(7):648-55. PubMed ID: 18500732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.
    Olivier KN; Weber DJ; Wallace RJ; Faiz AR; Lee JH; Zhang Y; Brown-Elliot BA; Handler A; Wilson RW; Schechter MS; Edwards LJ; Chakraborti S; Knowles MR;
    Am J Respir Crit Care Med; 2003 Mar; 167(6):828-34. PubMed ID: 12433668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of mortality in adults with cystic fibrosis.
    Courtney JM; Bradley J; Mccaughan J; O'Connor TM; Shortt C; Bredin CP; Bradbury I; Elborn JS
    Pediatr Pulmonol; 2007 Jun; 42(6):525-32. PubMed ID: 17469153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health related quality of life in cystic fibrosis: To work or not to work?
    Havermans T; Colpaert K; Vanharen L; Dupont LJ
    J Cyst Fibros; 2009 May; 8(3):218-23. PubMed ID: 19328745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
    J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistently inconsistent: a snapshot of across- and within-state disparities in the prevalence of childhood overweight and obesity.
    Bethell C; Read D; Goodman E; Johnson J; Besl J; Cooper J; Simpson LA
    Pediatrics; 2009 Jun; 123 Suppl 5():S277-86. PubMed ID: 19470604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients.
    Fluge G; Olesen HV; Gilljam M; Meyer P; Pressler T; Storrösten OT; Karpati F; Hjelte L
    J Cyst Fibros; 2009 May; 8(3):198-202. PubMed ID: 19303374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis.
    Amadori A; Antonelli A; Balteri I; Schreiber A; Bugiani M; De Rose V
    Respir Med; 2009 Mar; 103(3):407-13. PubMed ID: 19027279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum zinc concentrations in cystic fibrosis patients aged above 4 years: a cross-sectional evaluation.
    Van Biervliet S; Van Biervliet JP; Vande Velde S; Robberecht E
    Biol Trace Elem Res; 2007 Oct; 119(1):19-26. PubMed ID: 17914215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.
    Sims EJ; Clark A; McCormick J; Mehta G; Connett G; Mehta A;
    Pediatrics; 2007 Jan; 119(1):19-28. PubMed ID: 17200267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe bone demineralisation is associated with higher mortality in children with cystic fibrosis.
    O'Reilly R; Fitzpatrick P; Leen G; Elnazir B; Greally P
    Ir Med J; 2009 Feb; 102(2):47-9. PubMed ID: 19405318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of liver disease in cystic fibrosis.
    Lindblad A; Glaumann H; Strandvik B
    Hepatology; 1999 Nov; 30(5):1151-8. PubMed ID: 10534335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis-related diabetes in adults.
    Cawood TJ; McKenna MJ; Gallagher CG; Smith D; Chung WY; Gibney J; O'Shea D
    Ir Med J; 2006 Mar; 99(3):83-6. PubMed ID: 16700261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.